BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 23810369)

  • 1. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome.
    García-Molina E; Lacunza J; Ruiz-Espejo F; Sabater M; García-Alberola A; Gimeno JR; Cañizares F; García A; Martínez P; Valdés M; Tovar I
    Clin Genet; 2013 Jun; 83(6):530-8. PubMed ID: 22984773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.
    Hothi SS; Ara F; Timperley J
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):93-7. PubMed ID: 24903439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
    Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic and molecular basis for sodium channel-mediated Brugada syndrome].
    Barajas-Martínez H; Hu D; Antzelevitch C
    Arch Cardiol Mex; 2013; 83(4):295-302. PubMed ID: 24269159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome.
    Santos LF; Rodrigues B; Moreira D; Correia E; Nunes L; Costa A; Elvas L; Pereira T; Machado JC; Castedo S; Henriques C; Matos A; Santos JO
    Europace; 2012 Jun; 14(6):882-8. PubMed ID: 22277643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
    Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
    Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinic and genetic polymorphism of Brugada syndrome in Russian patients, caused by mutation in SCN5A gene].
    Zakliaz'minskaia EV; Shestak AG; Revishvili ASh; Pronicheva IV; Podoliak DG; Nechaenko MA; Poliakov AV; Dzemeshkevich SL
    Khirurgiia (Mosk); 2013; (2):49-53. PubMed ID: 23503384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
    Hong K; Brugada J; Oliva A; Berruezo-Sanchez A; Potenza D; Pollevick GD; Guerchicoff A; Matsuo K; Burashnikov E; Dumaine R; Towbin JA; Nesterenko V; Brugada P; Antzelevitch C; Brugada R
    Circulation; 2004 Nov; 110(19):3023-7. PubMed ID: 15520322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:
    Hong K; Berruezo-Sanchez A; Poungvarin N; Oliva A; Vatta M; Brugada J; Brugada P; Towbin JA; Dumaine R; Piñero-Galvez C; Antzelevitch C; Brugada R
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):64-9. PubMed ID: 15028074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.